[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345246-105":59,"doc-detail-345246-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","dogs-serum-proteomic-analysis-using-gel-based-liquid-chromatography-tandem-mass-spectrometry-reveals-differences-between-canine-oral-malignancies-and-non-malignant-conditions","Dogs - Serum Proteomic Analysis Using Gel-Based Liquid Chromatography Tandem Mass Spectrometry Reveals Differences Between Canine Oral Malignancies and Non-Malignant Conditions","","Background: Canine oral cancers are difficult to manage due to complex biology and limited non-invasive biomarkers. Proteomic approaches using gel-based liquid chromatography–tandem mass spectrometry (GeLC–MS/MS) have been applied to tissue and saliva, but serum biomarkers remain poorly understood despite clinical accessibility. Objectives: Assess GeLC–MS/MS for serum proteomic profiling in canine oral malignancies versus benign and healthy conditions.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dogs-serum-proteomic-analysis-using-gel-based-liquid-chromatography-tandem-mass-spectrometry-reveals-differences-between-canine-oral-malignancies-and-non-malignant-conditions/345246/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dogs-serum-proteomic-analysis-using-gel-based-liquid-chromatography-tandem-mass-spectrometry-reveals-differences-between-canine-oral-malignancies-and-non-malignant-conditions/345246.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is serum proteomics important for canine oral cancer research?","Question",{"text":113,"@type":114},"Serum is clinically accessible and can reflect systemic disease, but serum biomarkers for canine oral malignancies remain unclear. The study targets this gap using GeLC–MS/MS profiling.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were the serum samples grouped in the study?",{"text":118,"@type":114},"The study analyzed 62 serum samples from dogs with oral melanoma, oral squamous cell carcinoma, benign tumours, and controls (healthy/periodontitis). Proteomic profiling was performed using GeLC–MS/MS.",{"name":120,"@type":111,"acceptedAnswer":121},"Which proteins showed altered expression in oral melanoma and oral squamous cell carcinoma?",{"text":122,"@type":114},"In oral melanoma and oral squamous cell carcinoma, PDE4D was upregulated, while OAZ3, CCP110, NEK8, PTPRF, and IL23R were downregulated. These proteins relate to cancer-relevant pathways.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},345246,1790164579,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Veterinary Medicine and Science  \nORIGINAL ARTICLE   \nDogs  \nSerum Proteomic Analysis Using Gel-Based Liquid Chromatography Tandem Mass Spectrometry Reveals Differences Between Canine Oral Malignancies and Non-Malignant Conditions  \nSekkarin Ploypetch1   Sittiruk Roytrakul2   Janthima Jaresitthikunchai2  Narumon Phaonakrop2  Gunnaporn Suriyaphol3, 4   \n1 Department of Clinical Sciences and Public Health, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand  2National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani, Thailand  3 Biochemistry Unit, Department of Physiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand  4 Center of Excellence for Companion Animal Cancer, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand  \nCorrespondence: Sekkarin Ploypetch ([sekkarin.plo@mahidol.ac.th](sekkarin.plo@mahidol.ac.th))  Gunnaporn Suriyaphol (Gunnaporn.V@chula.ac.th)  \nReceived: 28 December 2025  Revised: 18 March 2026  Accepted: 13 April 2026  \nKeywords: dogs | GeLC–MS/MS | oral cancer | proteomics | serum  \nABSTRACT  \nBackground: Canine oral cancers are difficult to manage due to complex biology and a lack of non-invasive biomarkers. Proteomic approaches, particularly gel-based liquid chromatography–tandem mass spectrometry (GeLC–MS/MS), have been used on tissue and saliva, but serum remains obscure despite its clinical accessibility and ability to reflect systemic disease.  \nObjectives: This study evaluated GeLC–MS/MS for serum proteomic profiling in canine oral malignancies, compared to benign and healthy conditions.  \nMethods: We analysed 62 serum samples from dogs with oral melanoma (OM, n = 28), oral squamous cell carcinoma (OSCC, n = 10), benign tumours (BN, n = 12) and controls (healthy/periodontitis, n = 12) using GeLC–MS/MS-based proteomics.  \nResults: Significant protein expression differences emerged across groups. In OM and OSCC, phosphodiesterase 4D (PDE4D) was upregulated, while ornithine decarboxylase antizyme 3 (OAZ3), centriolar coiled–coil protein 110 (CCP110), non–specific serine/threonine protein kinase 8 (NEK8), receptor–type tyrosine–protein phosphatase F (PTPRF) and interleukin 23 receptor (IL23R) were downregulated. These proteins are linked to critical pathways, including insulin signalling, insulin resistance, adherens junctions and cell cycle regulation, highlighting their roles in cancer progression and showing potential interactions with common chemotherapy drugs like doxorubicin, cisplatin and cyclophosphamide.  \nConclusions: This study demonstrates that GeLC–MS/MS-based serum proteomics can successfully identify candidate biomarkers for canine oral malignancies. The discovery of these protein signatures represents promising diagnostic and prognostic targets, with the potential to guide chemotherapeutic selection and improve clinical outcomes in dogs with oral cancer.  \n1  Introduction  \nOral cavity tumours and tumour-like lesions are frequently observed during routine clinical examinations in dogs. These lesions often cause significant discomfort, pain and difficulty in eating (Verhaert 2010) . The World Health Organisation (WHO)  \ndefines oral potentially malignant disorders (OPMDs) as precancerous lesions with an elevated risk of progressing to oral cancer, encompassing various oral mucosal conditions susceptible to malignant transformation (Gupta et al. 2018) . Previous studies have shown that oral cancer can develop without noticeable symptoms in its early stages and may arise either de novo or  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.  \n© 2026 The Author(s) . Veterinary Medicine and Science published by John Wiley & Sons Ltd.  \nVeterinary Medicin","cbCaisj936ftO1J0","https://ap.wps.com/l/cbCaisj936ftO1J0","pdf",2402563,12,"English","# Abstract\n## Background\n## Objectives\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"Why is serum proteomics important for canine oral cancer research?\",\"answer\":\"Serum is clinically accessible and can reflect systemic disease, but serum biomarkers for canine oral malignancies remain unclear. The study targets this gap using GeLC–MS/MS profiling.\"},{\"question\":\"How were the serum samples grouped in the study?\",\"answer\":\"The study analyzed 62 serum samples from dogs with oral melanoma, oral squamous cell carcinoma, benign tumours, and controls (healthy/periodontitis). Proteomic profiling was performed using GeLC–MS/MS.\"},{\"question\":\"Which proteins showed altered expression in oral melanoma and oral squamous cell carcinoma?\",\"answer\":\"In oral melanoma and oral squamous cell carcinoma, PDE4D was upregulated, while OAZ3, CCP110, NEK8, PTPRF, and IL23R were downregulated. These proteins relate to cancer-relevant pathways.\"}]","Dogs - Serum Proteomic Analysis Using Gel-Based Liquid Chromatography Tandem Mass Spectrometry Reveals Differences Between Canine Oral Malignancies and Non-Malignant Conditions | PDF",1790056943,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c0ad65d089bedd2704bcb245a8d7705.webp",983,1283,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9185b6959dc642f8fb00c8336548af4f.webp",982,1281,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d373bb12a9a72fdaba403069df684a7.webp",981,1280,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6508eab063518d697a2dd93a2185e6af.webp",980,1279]